YAP Therapeutics
Laguna Hills, US · Delaware corporation
Biotech
Founders & leadership
AB
Andrew B. WadeExecutive Officer
OB
Olav B. BergheimExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$30.1MraisedJan 2022 · 6 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Andrew B. WadeExecutive Officer
- Olav B. BergheimExecutive Officer, Director
- Offering amount
- $30.1M
- Amount sold
- $30.1M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.